Nodding Syndrome Completed Phase 1 Trials for Lorazepam (DB00186)

IndicationStatusPhase
DBCOND0003622 (Nodding Syndrome)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02462109Catatonia in Nodding Syndrome and Lorazepam TreatmentSupportive Care